Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 331
Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review
Gianna Di Sario, Valeria Rossella, Elvira Smeralda Famulari, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 23
Relationship between 4-Hydroxynonenal (4-HNE) as Systemic Biomarker of Lipid Peroxidation and Metabolomic Profiling of Patients with Prostate Cancer
Matea Nikolac Perković, Morana Jaganjac, Lidija Milković, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 145-145
Open Access | Times Cited: 21
Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
Murad Alahdal, Roshane Perera, Márcio Covas Moschovas, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 27-38
Open Access | Times Cited: 18
Dual-mode fluorescence and colorimetric smartphone-based sensing platform with oxidation-induced self-assembled nanoflowers for sarcosine detection
Peng Liu, Qian Sun, Zhexu Gai, et al.
Analytica Chimica Acta (2024) Vol. 1306, pp. 342586-342586
Closed Access | Times Cited: 7
Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis
Mahmoud Assem Hamed, Valerie C. Wasinger, Qi Wang, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 126-145
Open Access | Times Cited: 7
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6281-6281
Open Access | Times Cited: 23
The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis
Huayan Xu, Xiaotang Cai, Ke Xu, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy
Chen Yan, Dan Wu, Lingling Gan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case–Control Study
Daniel Pardo-Rodriguez, Mary Santamaría-Torres, Angela Salinas, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5465-5465
Open Access | Times Cited: 6
Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
Saïda Mebarek, Najwa Skafi, Leyre Brizuela
Cancers (2023) Vol. 15, Iss. 10, pp. 2732-2732
Open Access | Times Cited: 5
Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: A systematic review
Yamilé López‐Hernández, Cristina Andrés‐Lacueva, David S. Wishart, et al.
Translational Oncology (2024) Vol. 51, pp. 102196-102196
Closed Access | Times Cited: 1
Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review
Navneeta Bansal, Manoj Kumar, Satyanarayan Sankhwar, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Closed Access | Times Cited: 7
Identification of biomarkers associated with the feed efficiency by metabolomics profiling: results from the broiler lines divergent for high or low abdominal fat content
Zhiyong Su, Xue Bai, Haoyu Wang, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Metabolic fingerprinting of chemotherapy-resistant prostate cancer stem cells. An untargeted metabolomic approach by liquid chromatography-mass spectrometry
Alicia Bort, Belén G. Sánchez, Carlos León, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4
Analysis of non-targeted serum metabolomics in patients with chronic kidney disease and hyperuricemia
Wenyu Yang, Jun Wang, Xiaohan Li, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 4, pp. 4013-4039
Closed Access | Times Cited: 2
Comprehensive biomarker profiles and chemometric filtering of urinary metabolomics for effective discrimination of prostate carcinoma from benign hyperplasia
Eleonora Amante, Andrea Cerrato, Eugenio Alladio, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Detection of Prostate Cancer and Benign Prostatic Hyperplasia Using Prostate-Specific Antigen Testing: A Review of Clinical Research Studies
Md Azizul Islam, Md Jawadul Haque, Mokther Hossain, et al.
Journal of Bio-Science (2024) Vol. 31, Iss. 2, pp. 55-66
Open Access
Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3–5 not receiving dialysis
Lingling Gan, Lijun Wang, Wanyi Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Study on potential markers for diagnosis of renal cell carcinoma by serum untargeted metabolomics based on UPLC-MS/MS
Jun Wang, Wenyu Yang, Xiaohan Li, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 2
Page 1

Scroll to top